SOOLANTRA: payments to doctors
Payments that named SOOLANTRA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 4,156
- Transactions
- 19,111
- Average per transaction
- $71
The per-transaction average — $71 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,156 providers the average total is $326, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Galderma Laboratories, L.p. | $1,242,176 | 91.7% |
| Galderma International SAS | $112,304 | 8.3% |